298 related articles for article (PubMed ID: 15563548)
1. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
[TBL] [Abstract][Full Text] [Related]
2. GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells.
Sadowski CL; Wheeler TT; Wang LH; Sadowski HB
Endocrinology; 2001 Sep; 142(9):3890-900. PubMed ID: 11517167
[TBL] [Abstract][Full Text] [Related]
3. SOCS2 negatively regulates growth hormone action in vitro and in vivo.
Greenhalgh CJ; Rico-Bautista E; Lorentzon M; Thaus AL; Morgan PO; Willson TA; Zervoudakis P; Metcalf D; Street I; Nicola NA; Nash AD; Fabri LJ; Norstedt G; Ohlsson C; Flores-Morales A; Alexander WS; Hilton DJ
J Clin Invest; 2005 Feb; 115(2):397-406. PubMed ID: 15690087
[TBL] [Abstract][Full Text] [Related]
4. Knock your SOCS off!
Leroith D; Nissley P
J Clin Invest; 2005 Feb; 115(2):233-6. PubMed ID: 15690080
[TBL] [Abstract][Full Text] [Related]
5. Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice.
Michaylira CZ; Ramocki NM; Simmons JG; Tanner CK; McNaughton KK; Woosley JT; Greenhalgh CJ; Lund PK
Endocrinology; 2006 Apr; 147(4):1632-41. PubMed ID: 16410303
[TBL] [Abstract][Full Text] [Related]
6. Role of SOCS2 in growth hormone actions.
Turnley AM
Trends Endocrinol Metab; 2005 Mar; 16(2):53-8. PubMed ID: 15734145
[TBL] [Abstract][Full Text] [Related]
7. Alterations in growth hormone receptor abundance regulate growth hormone signaling in murine obstructive cholestasis.
Held MA; Cosme-Blanco W; Difedele LM; Bonkowski EL; Menon RK; Denson LA
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G986-93. PubMed ID: 15604202
[TBL] [Abstract][Full Text] [Related]
8. Lack of Socs2 expression causes the high-growth phenotype in mice.
Horvat S; Medrano JF
Genomics; 2001 Mar; 72(2):209-12. PubMed ID: 11401434
[TBL] [Abstract][Full Text] [Related]
9. Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor i/insulin signaling and caloric restriction.
Al-Regaiey KA; Masternak MM; Bonkowski M; Sun L; Bartke A
Endocrinology; 2005 Feb; 146(2):851-60. PubMed ID: 15498882
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells.
Fruchtman S; Simmons JG; Michaylira CZ; Miller ME; Greenhalgh CJ; Ney DM; Lund PK
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G342-50. PubMed ID: 15831713
[TBL] [Abstract][Full Text] [Related]
11. Liver-specific overexpression of the insulin-like growth factor-I enhances somatic growth and partially prevents the effects of growth hormone deficiency.
Liao L; Dearth RK; Zhou S; Britton OL; Lee AV; Xu J
Endocrinology; 2006 Aug; 147(8):3877-88. PubMed ID: 16709615
[TBL] [Abstract][Full Text] [Related]
12. Direct stimulation of bone mass by increased GH signalling in the osteoblasts of Socs2-/- mice.
Dobie R; MacRae VE; Huesa C; van't Hof R; Ahmed SF; Farquharson C
J Endocrinol; 2014 Oct; 223(1):93-106. PubMed ID: 25074853
[TBL] [Abstract][Full Text] [Related]
13. Resolving the growth-promoting and metabolic effects of growth hormone: Differential regulation of GH-IGF-I system components.
Norbeck LA; Kittilson JD; Sheridan MA
Gen Comp Endocrinol; 2007 May; 151(3):332-41. PubMed ID: 17376444
[TBL] [Abstract][Full Text] [Related]
14. Effect of suppressor of cytokine signaling 2 (SOCS2) on fat metabolism induced by growth hormone (GH) in porcine primary adipocyte.
Yang HL; Sun C; Sun C; Qi RL
Mol Biol Rep; 2012 Sep; 39(9):9113-22. PubMed ID: 22729878
[TBL] [Abstract][Full Text] [Related]
15. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
[TBL] [Abstract][Full Text] [Related]
16. SOCS2 induces neurite outgrowth by regulation of epidermal growth factor receptor activation.
Goldshmit Y; Walters CE; Scott HJ; Greenhalgh CJ; Turnley AM
J Biol Chem; 2004 Apr; 279(16):16349-55. PubMed ID: 14764607
[TBL] [Abstract][Full Text] [Related]
17. Sepsis-induced muscle growth hormone resistance occurs independently of STAT5 phosphorylation.
Hong-Brown LQ; Brown CR; Cooney RN; Frost RA; Lang CH
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E63-72. PubMed ID: 12644450
[TBL] [Abstract][Full Text] [Related]
18. SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice.
Zadjali F; Santana-Farre R; Vesterlund M; Carow B; Mirecki-Garrido M; Hernandez-Hernandez I; Flodström-Tullberg M; Parini P; Rottenberg M; Norstedt G; Fernandez-Perez L; Flores-Morales A
FASEB J; 2012 Aug; 26(8):3282-91. PubMed ID: 22562833
[TBL] [Abstract][Full Text] [Related]
19. Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling.
Yumet G; Shumate ML; Bryant DP; Lang CH; Cooney RN
Crit Care Med; 2006 May; 34(5):1420-7. PubMed ID: 16540952
[TBL] [Abstract][Full Text] [Related]
20. The aging suppressor klotho: a potential regulator of growth hormone secretion.
Shahmoon S; Rubinfeld H; Wolf I; Cohen ZR; Hadani M; Shimon I; Rubinek T
Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E326-34. PubMed ID: 24939736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
